Pharmacokinetics, Safety and Tolerability of Crinecerfont in Participants With Congenital Adrenal Hyperplasia Who Are Less Than 2 Years Old

NCT07187375 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
6
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Neurocrine Biosciences